Resources from the same session
262MO - Real-world validation of artificial intelligence-defined lung nodule malignancy score (qXR-LNMS) in predicting risk of lung cancer
Presenter: Deniz Koksal
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
11MO - AI-based prediction of long-term survival in NSCLC patients treated with immunotherapy: Insights from the multicentric APOLLO11 study
Presenter: Vanja Miskovic
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
297MO - Patterns of disease progression with durvalumab (D) after concurrent chemoradiotherapy (cCRT) in limited-stage small-cell lung cancer (LS-SCLC): Results from ADRIATIC
Presenter: Suresh Senan
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
239MO - Stratification of pleural mesothelioma patients for combined immunotherapy based on sarcomatoid component and tumour microenvironment markers in the IFCT-MAPS2 study
Presenter: Guillaume Tosato
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
135MO - Grading system of spread through air spaces is an independent predictor of recurrence in stage I invasive non-mucinous adenocarcinoma
Presenter: Joonseok Lee
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
136MO - Predictors of multidisciplinary tumor board adherence in stage III non-small cell lung cancer patients from a large multicenter study
Presenter: Markus Joerger
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
Invited Discussant 135MO and 136MO
Presenter: Sabina Berezowska
Session: Mini Oral session 2
Resources:
Slides
Webcast
137MO - Impact of cardiac substructure dose on cardiotoxicity and overall survival (OS) in early-stage non-small cell lung cancer (ES-NSCLC) patients receiving stereotactic ablative body radiotherapy (SABR): Data from the interim analysis of the LUNG HEART study
Presenter: Marzia Cerrato
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
189MO - Perioperative durvalumab in addition to neoadjuvant chemotherapy in patients with stage IIIa(N2) non-small cell lung cancer: Final analysis of the trial SAKK 16/14
Presenter: Sacha Rothschild
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
Invited Discussant 137MO and 189MO
Presenter: Yolande Lievens
Session: Mini Oral session 2
Resources:
Slides
Webcast